ALLIANCE A011203

Primary Category:

Treatment Protocols

Disease Category:

Breast, Breast Metastatic

Status:

Closed

A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women with Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer

NCT#02311933

A011203 will soon meet its accrual goal.  Therefore, EFFECTIVE MONDAY, April 17, 2017 at 4:30 pm ET, A011203 Pre-registration will permanently close to new patient accrual.